This prospective study revealed that baseline CTCs and the cCSC ratio (i.e., cancer status), as well as the CD8+ proportion and the CD4: CD8 ratio (i.e., host immune status), were significantly associated with the prognosis of HNSCC. This evidence concerns the gene CD4 and head and neck squamous cell carcinoma.